White & Case has advised Walmark — a portfolio company of Mid Europa Partners, and a major consumer healthcare player in Central and Eastern Europe — on its acquisition of Valosun a.s., which was advised by Havel, Holasek & Partners.
Valosun, with its Biopron brand, is the leading probiotic player in the Czech Republic and Slovakia, and also holds a significant market position in female urinal health with Uroval.
Walmark was advised by Patria, White & Case, and Deloitte.
Mid Europa Partners is a leading independent private equity firm focused on the growth markets of Central and Eastern Europe and Turkey. Operating from London, Budapest, Warsaw and Istanbul, Mid Europa Partners advises and manages funds of approximately EUR 4.3 billion.
The White & Case team advising Walmark consisted of Partners Michal Smrek and Alena Naatz, Associates Magda Olysarova, Jakub Mencl, Petr Topka, and Barbora Hrabcakova, and Tax Consultant Tomas Cibula.